Technical Analysis for THAR - Tharimmune, Inc.

Grade Last Price % Change Price Change
D 2.69 -5.61% -0.16
THAR closed down 5.61 percent on Friday, November 1, 2024, on 30 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Support Bullish -5.61%
MACD Bullish Centerline Cross Bullish -5.61%
Slingshot Bullish Bullish Swing Setup -5.61%
Wide Bands Range Expansion -5.61%
Upper Bollinger Band Touch Strength -5.61%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 23 hours ago
Up 10% about 23 hours ago
Rose Above Upper Bollinger Band 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tharimmune, Inc. is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or "uncontrollable itching" in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors. Tharimmune has a license agreement with OmniAb, Inc. to access the company's antibody discovery technology platform against specified targets.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Solid Tumors Autoimmune Disease Antibodies Oncology Cancer Immunotherapy Antibody Hepatology Inflammatory Primary Biliary Cholangitis

Is THAR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 101.25
52 Week Low 1.835
Average Volume 1,292,497
200-Day Moving Average 4.34
50-Day Moving Average 2.54
20-Day Moving Average 2.21
10-Day Moving Average 2.32
Average True Range 0.54
RSI (14) 55.75
ADX 30.1
+DI 55.91
-DI 14.06
Chandelier Exit (Long, 3 ATRs) 4.78
Chandelier Exit (Short, 3 ATRs) 3.44
Upper Bollinger Bands 2.96
Lower Bollinger Band 1.45
Percent B (%b) 0.82
BandWidth 68.33
MACD Line 0.04
MACD Signal Line -0.08
MACD Histogram 0.1172
Fundamentals Value
Market Cap 6.79 Million
Num Shares 2.53 Million
EPS -15.50
Price-to-Earnings (P/E) Ratio -0.17
Price-to-Sales 0.00
Price-to-Book 0.67
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.47
Resistance 3 (R3) 3.54 3.36 3.34
Resistance 2 (R2) 3.36 3.16 3.32 3.30
Resistance 1 (R1) 3.02 3.04 2.93 2.95 3.25
Pivot Point 2.84 2.84 2.79 2.80 2.84
Support 1 (S1) 2.50 2.64 2.41 2.43 2.13
Support 2 (S2) 2.32 2.52 2.28 2.08
Support 3 (S3) 1.98 2.32 2.04
Support 4 (S4) 1.91